Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#assertion>. }
Showing items 1 to 17 of
17
with 100 items per page.
- subject C0011777 "dexamethasone" assertion.
- subject C5203670 "COVID-19" assertion.
- object C1947944 "use" assertion.
- subject C0021027 "antibody" assertion.
- subject C3665580 "antibody" assertion.
- subject C1879316 "transfusion" assertion.
- subject C1621287 "antibody" assertion.
- subject C1167408 "antibody" assertion.
- subject C0005841 "transfusion" assertion.
- subject C0003241 "antibody" assertion.
- predicate select?q=TRIPLE_UID:fv8lr3bm-TRIPLE-ABSTRACT-11 "call" assertion.
- object C5383282 "convalescent plasma therapy" assertion.
- triple label "dexamethasone and COVID-19 antibody transfusion called convalescent plasma therapy s use" assertion.
- sentence label "Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus is responsible for the current pandemic - coronavirus disease 2019 (COVID)-19) plaguing the world Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus began spreading as early as January 2020 in the United States (US) and has recently become the leading cause of death amongst adults over 45 years of age Much of Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus's clinical presentation is already known, and there have been advances in Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus's successful treatment with a food and drug administration (FDA) approved antiviral medication called remdesivir, and other proven investigational methods with clinical benefits including dexamethasone and Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus antibody transfusion called convalescent plasma therapy However, the recommendations for other proven investigational methods with clinical benefits including dexamethasone and COVID-19 antibody transfusion called convalescent plasma therapy's use include COVID-19 confirmed patients requiring supplemental oxygen or other forms of respiratory support In this case report, we describe in detail a unique case of severe Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus infection that did not require any form of oxygen support hut was treated successfully with antiviral medications and steroids The purpose of this case report is to highlight in detail an unusual Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus presentation with rhabdomyolysis, myocarditis, and pancytopenia severe enough to require hospitalization and treatment with proven Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus therapy to achieve clinical resolution" assertion.
- assertion wasGeneratedBy "S&T TWOC project version 1" assertion.
- version value "1" assertion.
- Triple-UID select?q=TRIPLE_UID:fv8lr3bm-TRIPLE-ABSTRACT-11 "fv8lr3bm-TRIPLE-ABSTRACT-11" assertion.